I’ve had the privilege of serving in leadership roles in academia, nonprofits including SfN, and small companies advancing new ideas into practice. In each setting I’ve sought to foster collaboration, maintain a constructive outlook, and guide teams toward workable solutions to difficult challenges. As Chair of Pharmacology at Emory University for 25 years, I redirected our department’s research focus to molecular pharmacology, guided it from 45th to 8th in NIH rankings, and founded its current graduate program. In my decade as Executive Associate Dean of Research at Emory, I created and implemented strategic plans that strengthened team science, managed extensive research infrastructure, and initiated award programs recognizing faculty innovation and excellence. My involvement with SfN includes 15 years chairing the Investment Committee, where we built a diversified, socially responsible portfolio that supports future growth. These experiences collectively prepare me to lead SfN as President. See the intr...